Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0641-6030-01 · Fentanyl Citrate Injection · Hikma Pharmaceuticals USA, Inc.
What is the package ndc for 0641-6030-01 · Fentanyl Citrate Injection · Hikma Pharmaceuticals USA, Inc.?
For 0641-6030-01 · Fentanyl Citrate Injection · Hikma Pharmaceuticals USA, Inc., package ndc is 0641-6030-01; generic name is Fentanyl Citrate Injection; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.
"initial_posting_date": "12/20/2023", "package_ndc": "0641-6030-01", "generic_name": "Fentanyl Citrate Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available September 2026 timeframe. Product will be made available as it is released."
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0641-6030-01 verified
- Generic name
- Fentanyl Citrate Injection verified
- Manufacturer
- Hikma Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Additional lots will be available September 2026 timeframe. Product will be made available as it is released. verified
- Initial posting date
- 12/20/2023 verified
- Last update date
- 08/13/2026 verified
- Days in shortage
- 986 our reading
- Reason for shortage
- Demand increase for the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Analgesia/Addiction verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/13/2026", "therapeutic_category": [ "Analgesia/Addiction", "Pediatric" ], "dosage_form": "Injection", "presentation": "Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
The same source also states
"initial_posting_date": "12/20/2023", "package_ndc": "0641-6030-01", "generic_name": "Fentanyl Citrate Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released."
— api.fda.gov, retrieved 2026-09-07
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000